Lyra Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Lyra Therapeutics

10/11/2021 07:35

* Lyra Therapeutics Inc  LYRA.OQ  reported a quarterly adjusted
loss of 85 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 73 cents per share.
* Revenue was $14.00 thousand​;  analysts expected $400.00
thousand. 
* Lyra Therapeutics Inc's reported EPS for the quarter was a
loss of 85 cents​.
* The mean earnings estimate of analysts had fallen by
about 9.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Lyra Therapeutics Inc shares had fallen by 25.6% this
quarter and lost 40.4% so far this year.
* The company reported a quarterly loss of $11.06 million.
* Wall Street's median 12-month price target for Lyra
Therapeutics Inc is $25.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 07:35 a.m.
 ​All figures in US dollars unless otherwise stated